Three Types of Nucleotide/Nucleoside Analogues Therapy in Patients With Hepatitis b Virus Related Compensated Cirrhosis
Status:
Recruiting
Trial end date:
2023-12-01
Target enrollment:
Participant gender:
Summary
This study is to investigate the clinical efficacy and safety of three types of
nucleotide/nucleoside analogues in treatment of hepatitis b virus related compensated
cirrhosis.